Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Chiang

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
The American Journal of Surgical Pathology|March 20, 2018
NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of FibrosarcomaSarah Chiang, Paolo Cotzia, David M Hyman, et al.
Gynecologic Oncology|August 26, 2020
State of the science: Uterine sarcomas: From pathology to practiceAlexander Shushkevich, Premal H Thaker, Ramey D Littell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovaryLindsey Finch, Sarah Andres, Alexia Iasonos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphologySarah Chiang, Cheng-Han Lee, Colin J R Stewart, et al.
JCO Precision Oncology|December 7, 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway GenesEvan Rosenbaum, Philip Jonsson, Kenneth Seier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2025
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous CarcinomaJoyce F Liu, Nicoletta Colombo, Amit M Oza, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic MarkerFelix K F Kommoss, Lisa-Marie Mar, Brooke E Howitt, et al.
The American Journal of Surgical Pathology|September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangementCheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
Scientific Reports|November 16, 2019
Functional and topographic effects on DNA methylation in IDH1/2 mutant cancersRamona Bledea, Varshini Vasudevaraja, Seema Patel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2019
Whole slide imaging equivalency and efficiency study: experience at a large academic centerMatthew G Hanna, Victor E Reuter, Meera R Hameed, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
The American Journal of Surgical Pathology|March 20, 2018
NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of FibrosarcomaSarah Chiang, Paolo Cotzia, David M Hyman, et al.
Gynecologic Oncology|August 26, 2020
State of the science: Uterine sarcomas: From pathology to practiceAlexander Shushkevich, Premal H Thaker, Ramey D Littell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovaryLindsey Finch, Sarah Andres, Alexia Iasonos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphologySarah Chiang, Cheng-Han Lee, Colin J R Stewart, et al.
JCO Precision Oncology|December 7, 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway GenesEvan Rosenbaum, Philip Jonsson, Kenneth Seier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2025
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous CarcinomaJoyce F Liu, Nicoletta Colombo, Amit M Oza, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic MarkerFelix K F Kommoss, Lisa-Marie Mar, Brooke E Howitt, et al.
The American Journal of Surgical Pathology|September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangementCheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
Scientific Reports|November 16, 2019
Functional and topographic effects on DNA methylation in IDH1/2 mutant cancersRamona Bledea, Varshini Vasudevaraja, Seema Patel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2019
Whole slide imaging equivalency and efficiency study: experience at a large academic centerMatthew G Hanna, Victor E Reuter, Meera R Hameed, et al.
Pageof 11